Impact of drugs on venous thromboembolism risk in surgical patients

被引：0
|
作者：
Alenka Premuš Marušič Kovačič
Martin Caprnda
Aleš Mrhar
Peter Kubatka
Igor Locatelli
Barbora Zolakova
Ludovit Gaspar
Robert Prosecky
Peter Kruzliak
Robert Staffa
Luis Rodrigo
Jozef Radonak
Danijel Petrovič
机构：
[1] Murska Sobota General Hospital,Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy
[2] University of Ljubljana,1st Department of Internal Medicine, Faculty of Medicine
[3] University Hospital and Comenius University in Bratislava,Department of Medical Biology, Jessenius Faculty of Medicine
[4] Comenius University in Bratislava,Department of Experimental Carcinogenesis, Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine
[5] Comenius University in Bratislava,Department of Internal Medicine
[6] Brothers of Mercy Hospital,2nd Department of Surgery, Faculty of Medicine
[7] Masaryk University and St. Anne’s University Hospital,Faculty of Medicine
[8] University of Oviedo,1st Department of Surgery, Faculty of Medicine
[9] Central University Hospital of Asturias (HUCA),Faculty of Medicine
[10] Pavol Jozef Safarik University and University Hospital,undefined
[11] University of Ljubljana,undefined
来源：
European Journal of Clinical Pharmacology | 2019年 / 75卷
关键词：
Venous thromboembolism; Analgesics; Diuretics; Antidepressants; Antipsychotics; Oral contraceptives; Surgery; Bridging anticoagulation; Transfusion; Thromboprophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：751 / 767
页数：16
相关论文
共 50 条
  • [21] Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients
    Betancourt, M. T.
    Rodger, M. A.
    ACTA CHIRURGICA BELGICA, 2007, 107 (06) : 636 - 640
  • [22] Lipid lowering drugs and the risk of recurrent venous thromboembolism
    Delluc, A.
    Le Moigne, E.
    Tromeur, C.
    Rolland, F.
    Couturaud, F.
    Le Gal, G.
    Mottier, D.
    Lacut, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 406 - 406
  • [23] Venous Thromboembolism Risk With Antidepressants: Driven by Disease or Drugs?
    Branchford, Brian R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [24] Lipid lowering drugs and the risk of recurrent venous thromboembolism
    Delluc, Aurelien
    Tromeur, Cecile
    Le Moigne, Emmanuelle
    Nowak, Emmanuel
    Mottier, Dominique
    Le Gal, Gregoire
    Lacut, Karine
    THROMBOSIS RESEARCH, 2012, 130 (06) : 859 - 863
  • [25] Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival
    Jeon, Hye Kyung
    Kim, Dong Uk
    Baek, Dong Hoon
    Ha, Dong Woo
    Lee, Bong Eun
    Ryu, Dong Yup
    Cheong, Jae Hoon
    Kim, Gwang Ha
    Song, Geun Am
    Jang, Ae Lee
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (04) : 444 - 449
  • [26] An impact evaluation of an education bundle for patients at risk of developing venous thromboembolism
    Boyer, Nicole
    Skinner, Robert
    Breck, Andrew
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (08) : 563 - 574
  • [27] The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients
    Gross, Cary P.
    Galusha, Deron H.
    Krumholz, Harlan M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (03) : 321 - 326
  • [28] The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients
    Cary P. Gross
    Deron H. Galusha
    Harlan M. Krumholz
    Journal of General Internal Medicine, 2007, 22 : 321 - 326
  • [29] Antipsychotic drugs may increase the risk of venous thromboembolism
    Adis Medical Writers
    Drugs & Therapy Perspectives, 2018, 34 (8) : 372 - 376
  • [30] Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism
    Kahn, Susan R.
    Morrison, David R.
    Cohen, Jacqueline M.
    Emed, Jessica
    Tagalakis, Vicky
    Roussin, Andre
    Geerts, William
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (07):
12345